EcoDrugPlus

Retinoic Acid Receptor Beta

Ensembl ID : ENSOSIG00000004186
Gene Symbol: RARB
1 Cross references
393 Possible Orthologues:

Retinoic Acid Receptor Gamma

Ensembl ID : ENSOSIG00000010846
Gene Symbol: RARG
1 Cross references
353 Possible Orthologues:

Rho-Associated, Coiled-Coil Containing Protein Kinase 2a

Ensembl ID : ENSOSIG00000010469
Gene Symbol: ROCK2A
1 Cross references
225 Possible Orthologues:

Rho-Associated, Coiled-Coil Containing Protein Kinase 2b

Ensembl ID : ENSOSIG00000011933
Gene Symbol: ROCK2B
1 Cross references
225 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSOSIG00000014249
Gene Symbol: RPL11
1 Cross references
286 Possible Orthologues:

Ribosomal Protein L12

Ensembl ID : ENSOSIG00000001355
Gene Symbol: RPL12
1 Cross references
462 Possible Orthologues:

Ribosomal Protein L12

Ensembl ID : ENSOSIG00000002237
Gene Symbol: RPL12
1 Cross references
462 Possible Orthologues:

Ribosomal Protein L13

Ensembl ID : ENSOSIG00000013296
Gene Symbol: RPL13
1 Cross references
274 Possible Orthologues:

Ribosomal Protein L13a

Ensembl ID : ENSOSIG00000018574
Gene Symbol: RPL13A
1 Cross references
368 Possible Orthologues:

Ribosomal Protein L14

Ensembl ID : ENSOSIG00000005222
Gene Symbol: RPL14
1 Cross references
309 Possible Orthologues:

Ribosomal Protein L15

Ensembl ID : ENSOSIG00000007616
Gene Symbol: RPL15
1 Cross references
357 Possible Orthologues:

Ribosomal Protein L17

Ensembl ID : ENSOSIG00000004724
Gene Symbol: RPL17
1 Cross references
707 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).